🔥 Monday 11 May 2026 Mon, 11 May 2026

Dyno Nobel’s explosives business drove a 28% EBIT jump in 1H26 as the company completed $558m of its $900m buyback and sealed the sale of its fertilisers unit.

Dateline Resources has delivered a comprehensive Bankable Feasibility Study for its Colosseum Gold Project in California, outlining a technically straightforward restart with strong financial metrics and a 10.4-year mine life producing 573,000 ounces of gold.

Bioxyne expands its LATAM footprint by securing the first international medicinal cannabis flower supply agreement in Costa Rica, with initial shipments valued over $500,000 planned before June 2026.

BCAL Diagnostics appoints Anne-Louise Arnett as CEO effective June 2026, aiming to accelerate its commercial rollout and international market entry of early cancer detection tests.

Inghams Group has unveiled a comprehensive strategy to stabilise operations, optimise assets, and grow value, reaffirming FY26 EBITDA guidance between $180 million and $200 million amid ongoing cost pressures.

Power Minerals has kicked off a 3,800-metre diamond drilling campaign at its Morro do Ferro Rare Earths Project in Brazil, aiming to expand high-grade rare earth mineralisation and advance metallurgical studies following recent acquisition completion.

Navigator Global Investments (ASX: NGI) has kicked off a fully underwritten entitlement offer to raise A$145 million, supporting its US$195 million acquisition of a portfolio of alternative asset manager stakes from Stable Asset Management.

Advanced Energy Minerals (ASX:AEM) is partnering with NeoCtech to pilot rare earth doped nano high purity alumina, backed by an $800,000 CAD Canadian government grant. The project targets strategic sectors including AI, robotics, and aerospace with sustainable, high-performance materials.

Strike Energy shakes up leadership with Shelley Robertson stepping in as CEO and a leaner board under new chair Nev Power, signaling a strategic pivot amid ongoing project development.

oOh!media has dismissed two non-binding takeover bids, including a fresh A$1.45 per share offer from I Squared Capital, while inviting revised proposals and pausing its share buyback.

Raiden Resources has uncovered extensive new arsenic-in-soil anomalies at its Vuzel Gold Project in Bulgaria, signaling a potentially larger mineralised system beyond the previously drilled zone. Follow-up exploration and permitting efforts continue alongside pending metallurgical test results.

Lodestar Minerals has identified five new copper-molybdenum-gold porphyry targets at Los Loros, Chile, and confirmed encouraging IOCG-style alteration at Three Saints, setting the stage for maiden drilling campaigns.

Adisyn’s subsidiary 2D Radar has teamed with Israeli plastics giant Raval to fast-track graphene-enhanced stealth parts for drones, aiming to compress development-to-production timelines from years to months.

Elevra Lithium has struck a US$71 million deal to offload its Ghanaian Ewoyaa Project interest to Zhejiang Huayou Cobalt, pivoting its strategy firmly towards North American assets while shedding funding obligations tied to Ewoyaa.

Pure Resources has launched an integrated Defence Materials Platform Strategy for its Garnet Hills Project, leveraging US government collaborations to diversify from commodity mining into advanced defence supply chains.

Golden Dragon Mining’s latest RC drilling at Coodardy delivers standout high-grade gold intersections including 12m at 6.5 g/t Au, revealing a new mineralised north-east orientation and expanding growth potential.

Redcastle Resources' recent diamond drilling at Redcastle Reef and Queen Alexandra validates geological models and reveals promising mineralisation extensions, bolstering confidence in near-term mining plans.

Pantoro Gold has identified a substantial high-grade gold zone at its Racetrack Target, adjacent to the OK Underground Mine, promising to boost production capacity at Norseman.

CSL Limited’s interim CEO Gordon Naylor reveals a downgraded FY26 outlook amid slower growth and announces substantial impairments tied to CSL Vifor assets. Leadership changes and transformation efforts aim to restore momentum.

Pacific Edge is raising NZ$24 million to shore up its finances and support a crucial Medicare re-coverage bid following a steep revenue drop after losing Medicare reimbursement for its bladder cancer test. The company eyes a draft Medicare policy by September 2026 as a potential turning point.